This page has moved. Click here to view.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Medical Library. Full Text Journals Medical Books Online. Physicians Drug Reference

Color Atlas of Skin Diseases

C *CA 19-9 -- Cancer -- Cancrum oris (noma) -- Capnocytophaga ochracea Capnocytophaga sputigena -- Carcinoma(s) Carcinoma -- Cardiac output Cardiac performance, control of -- Cardinal manifestations and presentation of disease Cardiobacterium hominis -- Cardiovascular disease Cardiovascular system -- Cefuroxime -- Celiac catheterization, for pancreatic disease -- Central nervous system -- Central venous access, for parenteral nutrition -- Cervical spondylosis Cervicitis, mucopurulent (MPC) -- Chemoprevention, of cancer Chemoreceptor trigger zone -- Chemotherapy Chenodeoxycholate (CDCA) -- Chlamydial infections Chlamydia pneumoniae -- Chloroquine Chlorothiazide, for heart failure -- Cholera (Vibrio cholerae) Cholera vaccine -- Chromatin Chromium -- Cidofovir Cigar smoking -- Cirrhosis Cisapride -- Clonidine Cloning -- Coagulation disorders Coagulation factor(s) -- Cognitive dysfunction Cognitive evoked potentials -- Colon cancer Colonic diverticula -- Complement pathway Complement system -- Congenital heart disease Congenital muscular dystrophy -- Copolymer I (COP-I), for multiple sclerosis Copper -- Cortisol Cortisol-binding globulin (CGB; transcortin) -- Cranial nerves Cranial neuralgias -- Cryptococcosis (Cryptococcus neoformans) Cryptogenic fibrosing alveolitis -- Cyanosis Cyclic AMP response element binding (CREB) -- Cystic fibrosis Cystic teratomas, and chronic anovulation -- Cytomegalovirus (CMV) Cytosine arabinoside -- Cytotoxins

 

CA 19-9 [ch81 Table3]

and pancreatic cancer

CA 125 [ch81 Table3] [ch99 ¶8] [ch99 ¶10] [ch99 ¶21] [ch101 ¶9]

for ovarian cancer [ch82 ¶50]

Cachectin

 

[see: Tumor necrosis factor ]

Cache Valley virus [ch200 ¶23]

Cachexia

in cancer [ch81 ¶41]

in heart failure [ch233 ¶44]

Cacosmia [ch28 ¶8]

Cadherins, and cancer invasion [ch85 ¶11-¶12]

Cadmium poisoning [ch397 ¶37-¶41]

clinical toxicology [ch397 ¶39]

laboratory findings [ch397 ¶40]

and lung disease [ch254 Table1]

metabolism [ch397 ¶38]

source [ch397 ¶37]

treatment [ch397rx4]

Café au lait spots [ch57 ¶40] [ch375 ¶57]

Calabar swellings [ch223 ¶34]

Calciferol [ch353 ¶49]

 

[see also: Vitamin D]

Calcific tendinitis [ch326 ¶75]

Calcinosis

cutis [ch57 ¶68]

metastatic [ch57 ¶68]

tumor [ch353 ¶26]

Calcitonin [ch353 ¶77-¶84]

catecholamines and [ch70 ¶49]

for hypercalcemia [ch102 ¶12] [ch354 ¶127]

measurement, in diarrhea [ch42 ¶52]

for osteoporosis [ch355 ¶33]

for Paget's disease [ch358 ¶15-¶16]

as tumor marker [ch81 Table3]

Calcitriol [ch353 ¶49]

for rickets/osteomalacia [ch355 ¶66]

Calcium

absorption [ch285 ¶24] [ch285 Table2]

and cardiac activation [ch232 Figure4] [ch232 ¶8-¶9]

deficiency

 

[see also: Hypocalcemia]

pathophysiology [ch353 ¶19-¶20]

dietary intake [ch353 ¶14]

disorders [ch354]

in pregnancy [ch7 ¶37]

endogenous fecal [ch353 ¶15]

excess

 

[see also: Hypercalcemia]

pathophysiology [ch353 ¶19-¶20]

excretion [ch353 ¶15-¶16]

G protein and [ch83 ¶26]

and heart failure [ch232 ¶57]

and hypertension [ch246 ¶12]

idiopathic lithiasis [ch279 ¶31]

in illness [ch73 Table1]

malabsorption test [ch285 ¶35]

metabolism [ch353 Figure2] [ch353 ¶11-¶20]

for osteoporosis [ch355 ¶31-¶32] [ch355 Table2]

recommended dietary allowance (RDA) [ch72 Table1]

regenerative release [ch232 ¶8]

in renal failure, chronic (CRF) [ch271 Figure2] [ch271 ¶5] [ch271 ¶20-¶24]

Calcium carbonate, for duodenal ulcers [ch284 ¶64]

Calcium channel, disorders of muscle [ch383 ¶128-¶132]

Calcium channel blockers

antiarrhythmic dosages [ch231 Table5]

antiarrhythmic effects of [ch231 Table2]

and continence [ch9 Table4]

for diarrhea [ch42 ¶54]

for hypertension [ch246 ¶71] [ch246 ¶72]

dosages and side effects [ch246 Table4]

for myocardial infarction [ch243 ¶65]

for myocardial ischemia [ch244 ¶57] [ch244 ¶59] [ch244 Table1]

poisoning/overdosage [ch391 ¶85-¶89]

diagnosis [ch391 ¶88]

toxicity [ch391 ¶87]

treatment [ch391rx9]

for pulmonary hypertension [ch260 ¶19]

for Raynaud's phenomenon [ch248 ¶52] [ch314 ¶44]

Calcium hydroxyapatite (HA) deposition disease [ch323 ¶1] [ch323 ¶9-¶14]

clinical manifestations [ch323 ¶11]

diagnosis [ch323 Figure2] [ch323 ¶12-¶13]

pathogenesis [ch323 ¶9-¶10] [ch323 Table2]

treatment [ch323 ¶14]

Calcium infusion test, in Zollinger-Ellison syndrome [ch284 ¶175]

Calcium oxalate (CaOx) deposition disease [ch323 ¶1] [ch323 ¶15-¶19] [ch349 ¶50-¶55]

clinical manifestations [ch323 Figure3] [ch323 ¶17-¶18]

hyperoxaluria of [ch349 ¶50-¶55]

pathogenesis [ch323 ¶15-¶16]

treatment [ch323 ¶19]

Calcium pyrophosphate dihydrate (CPPD) disease [ch323 ¶1] [ch323 ¶2-¶8]

clinical manifestations [ch323 Figure1] [ch323 ¶4-¶7]

pathogenesis [ch323 ¶2-¶3] [ch323 Table1] [ch323 Table2]

treatment [ch323rx1]

Calcium stones [ch268 ¶24]

renal [ch279 ¶1-¶2] [ch279 Table1]

 

[see also: Nephrolithiasis]

distal renal tubular acidosis [ch279 ¶26]

hyperoxaluria [ch279 ¶27-¶28]

treatment [ch279rx3]

hyperuricosuria [ch279 ¶25]

hypocitrauria [ch279 ¶29-¶30]

treatment [ch279rx4]

idiopathic calcium lithiasis [ch279 ¶31]

idiopathic hypercalciuria [ch279 ¶22]

treatment [ch279rx2]

Calculi (stones)

biliary

 

[see: Choledocholithiasis]

gallbladder

 

[see: Gallstones]

periodontal [ch31 ¶7]

renal

 

[see: Nephrolithiasis]

urinary bladder

Crohn's disease and [ch286 ¶32]

and Paget's disease [ch358 ¶9]

and voiding dysfunction [ch48 ¶8]

Caliciviridae [ch182 Figure1] [ch182 Table1]

Caliciviruses [ch194 ¶13-¶19]

clinical immunity [ch194 ¶18]

diagnosis, treatment, and prevention [ch194 ¶19]

epidemiology [ch194 ¶14]

manifestations [ch194 ¶17]

pathophysiology [ch194 ¶16]

California virus encephalitis [ch200 ¶44-¶48] [ch379 ¶40] [ch379 Table6]

Caloric restriction

aging and [ch9 ¶6]

for hypertension [ch246 ¶55]

Calovo virus [ch200 ¶23]

Calymmatobacterium granulomatosis [ch166]

 

[see also: Donovanosis]

Camptothecin, for cancer [ch86 ¶66]

Campylobacter [ch160]

arthritis [ch324 ¶35]

clinical manifestations [ch160 ¶9-¶10]

complications [ch160 ¶11-¶13]

defined [ch160 ¶1]

diarrhea [ch42 ¶17] [ch128 ¶24]

differential diagnosis [ch160 ¶15]

epidemiology [ch160 ¶3-¶5]

and HIV disease [ch160 ¶4] [ch160 ¶12] [ch308 ¶176] [ch308 ¶178] [ch308 ¶234]

travel and [ch123 ¶31]

laboratory findings [ch160 ¶14]

microbiology [ch160 ¶2]

logy [ch160 ¶6-¶8]

polyneuropathy [ch381 ¶36]

prognosis [ch160 ¶18]

treatment [ch160rx1]

Campylobacter coli [ch160 ¶2] [ch160 Table1]

Campylobacter fetus [ch160 ¶2] [ch160 Table1]

clinical manifestations [ch160 ¶9-¶10]

Campylobacter hyointestinalis [ch160 Table1]

Campylobacter jejuni [ch160]

 

[see also: Campylobacter]

differential diagnosis [ch286 ¶44]

and GI bleeding [ch44 ¶18]

Campylobacter lari [ch160 ¶2] [ch160 Table1]

Campylobacter sputorum [ch160 Table1]

Campylobacter upsaliensis [ch160 ¶2] [ch160 Table1]

Camurati-Engelman disease [ch359 ¶16]

Cancer

 

[see also: Neoplasia and individual organ tumors]

adrenal insufficiency and [ch104 ¶52]

airway obstruction and [ch104 ¶39]

approach to the patient [ch81]

Ball's disease and [ch104 ¶37]

biliary obstruction and [ch104 ¶18-¶19]

breast [ch91]

cachexia in [ch81 ¶41]

cardiac [ch241 ¶1-¶14]

cell biology [ch83]

C protein-linked receptors [ch83 ¶23-¶27] [ch83 Table2]

cytoskeleton and cell adhesion [ch83 ¶39-¶42]

enzyme-linked receptors [ch83 Figure3] [ch83 Figure4] [ch83 ¶28-¶38]

principles of cell cycle regulation [ch83 Figure1] [ch83 Figure2] [ch83 ¶7-¶16] [ch83 Table1]

regulation of cell death [ch83 ¶43-¶46]

regulation of gene transcription [ch83 ¶47-¶50]

signaling from outside cell to the nucleus [ch83 ¶17-¶38]

chemotherapy

 

[see: Chemotherapy]

chromosomal translocations [ch81 ¶6] [ch84 Table4]

clinical staging [ch81 ¶10]

clonal nature of [ch84 ¶1]

clostridial sepsis and [ch148 ¶33]

complications

long-term [ch81 ¶25-¶27]

treatment [ch81 ¶19-¶24]

defined [ch83 ¶1]

defining extent of disease [ch81 ¶9-¶15]

diagnosis [ch81 ¶6-¶8]

effusions from [ch81 ¶37-¶40]

emergencies [ch104]

in acute promyelocytic leukemia treatment [ch104 ¶75]

adrenal insufficiency [ch104 ¶52]

airway obstruction [ch104 ¶39]

Ball's disease [ch104 ¶37]

hemolytic-uremic syndrome [ch104 ¶60-¶64]

hemoptysis [ch104 ¶38]

hemorrhagic cystitis [ch104 ¶74]

hypercalcemia [ch104 ¶40-¶45]

hypoglycemia [ch104 ¶51]

increased intracranial pressure [ch104 ¶31-¶34]

intestinal obstruction [ch104 ¶12-¶14]

lactic acidosis [ch104 ¶50]

malignant biliary obstruction [ch104 ¶18-¶19]

metabolic [ch104 ¶40-¶53]

neutropenia and infection [ch104 ¶65]

pericardial effusion/tamponade [ch104 ¶9-¶11]

pulmonary infiltrates [ch104 ¶66-¶72]

seizures [ch104 ¶35-¶36]

SIADH [ch104 ¶46-¶49]

spinal cord compression [ch104 ¶20-¶29]

structural-obstructive [ch104 ¶2-¶39]

superior vena cava syndrome [ch104 ¶2-¶8]

treatment-related [ch104 ¶54-¶76]

tumor-lysis syndrome [ch104 ¶54-¶59]

typhlitis [ch104 ¶73]

urinary obstruction [ch104 ¶15-¶17]

end-of-life decisions [ch81 ¶50]

epidemiology [ch81 ¶2]

Epstein-Barr virus and [ch186 ¶20-¶21]

familial predisposition to [ch81 ¶5]

fever and [ch125 ¶10] [ch125 Table3]

gastrointestinal tract [ch92]

endocrine tumors [ch95]

genetics [ch84]

acquired mutations [ch84 Figure6] [ch84 ¶21-¶22] [ch84 Table3]

chromosomal alterations [ch84 Figure11] [ch84 ¶30-¶34] [ch84 Table4]

classes of cancer genes [ch84 ¶6-¶8]

complex inherited forms [ch84 Figure5] [ch84 ¶15-¶18]

DNA amplification [ch84 Figure9] [ch84 Figure10] [ch84 ¶27-¶29]

epigenetic regulation of gene expression [ch84 ¶35-¶36]

future research [ch84 ¶37-¶39]

mechanisms of somatic mutation of oncogenes [ch84 ¶25-¶34]

Mendelian syndromes [ch84 Figure1] [ch84 Figure2] [ch84 Figure3] [ch84 Figure4] [ch84 ¶9-¶14] [ch84 Table1] [ch84 Table2]

multistep basis of cancer [ch84 Figure7] [ch84 Figure8] [ch84 ¶23]

point mutation [ch84 ¶26]

RNA and DNA tumor viruses [ch84 ¶4]

testing and counseling [ch84 ¶19]

glomerular disease and [ch275 ¶63-¶64]

gynecologic [ch99]

head and neck [ch89]

hemolytic-uremic syndrome and [ch104 ¶60-¶64]

hemoptysis and [ch104 ¶38]

hemorrhagic cystitis and [ch104 ¶74]

hepatobiliary tract [ch93]

hypercalcemia and [ch104 ¶40-¶45]

hypoglycemia and [ch104 ¶51]

incidence [ch81 Figure1]

increased intracranial pressure and [ch104 ¶31-¶34]

infections and [ch87]

abnormalities that predispose to [ch87 ¶38-¶40]

antibacterial therapy for [ch87 ¶41-¶47]

antibiotic prophylaxis [ch87 ¶56]

antifungal therapy for [ch87 ¶48-¶49]

brain abscess [ch87 ¶24]

cardiovascular [ch87 ¶33]

catheter-related [ch87 ¶13-¶14]

central nervous system-specific syndromes [ch87 ¶22-¶24]

Clostridium difficile diarrhea [ch87 ¶21]

encephalitis [ch87 ¶23]

endocrine syndromes [ch87 ¶34]

gastrointestinal tract-specific syndromes [ch87 ¶15-¶21]

granulocyte transfusions for [ch87 ¶50-¶52]

hematopoietic disorders and [ch87 ¶39-¶40]

lower GI [ch87 ¶19]

lymphoid disorders and [ch87 ¶38]

musculoskeletal [ch87 ¶35]

predisposition [ch87 ¶2] [ch87 Table1]

prevention [ch87 ¶53-¶58]

pulmonary [ch87 ¶25-¶32] [ch87 Table5]

renal and ureteral [ch87 ¶36-¶37]

skin-specific syndromes [ch87 ¶7-¶12]

splenectomy and [ch87 ¶4] [ch87 Table2]

treatment [ch87 ¶41-¶52]

typhlitis [ch87 ¶20]

upper GI [ch87 ¶15-¶18]

vaccination and [ch87 ¶57-¶58]

intestinal obstruction and [ch104 ¶12-¶14]

invasion [ch85]

Karnofsky performance index [ch81 Table2]

lactic acidosis and [ch104 ¶50]

liver and biliary tract [ch93]

lung [ch90]

lymphoid cell malignancies [ch113]

management [ch81 ¶19-¶24]

metabolic emergencies [ch104 ¶40-¶53]

metastatic [ch85]

 

[see also: Metastases]

sites [ch81 ¶11] [ch85 Table1]

of unknown primary site [ch101]

mortality rates [ch81 Figure1] [ch81 Figure2] [ch81 ¶4]

nausea in [ch81 ¶33-¶36]

neoadjuvant therapy [ch81 ¶16]

neutropenia and infection in [ch104 ¶65]

nutritional care [ch81 ¶41-¶43]

pain in [ch81 ¶29-¶32]

pancreas [ch94]

endocrine tumors [ch95]

pathologic staging [ch81 ¶10]

patient management [ch81 ¶5-¶51]

pericardial effusion/tamponade and [ch104 ¶9-¶11]

pericarditis and [ch240 ¶30] [ch240 ¶36]

prevention and early detection [ch82]

prognosis [ch81 ¶9-¶15]

prostate [ch97]

psychosocial care [ch81 ¶44-¶45]

pulmonary infiltrates and [ch104 ¶66-¶72]

radiation therapy for [ch81 ¶16]

recurrence rates [ch81 ¶26]

renal and urinary tract [ch96]

renal parenchymal disease and [ch276 ¶26-¶28]

in renal transplantation [ch272 ¶58]

risk factors for [ch81 ¶3]

sarcomas [ch100]

seizures and [ch104 ¶35-¶36]

SIADH and [ch104 ¶46-¶49]

skin [ch88]

spinal cord compression and [ch104 ¶20-¶29]

staging [ch81 ¶10-¶12]

TNM [ch81 ¶12]

structural-obstructive emergencies [ch104 ¶2-¶39]

superior vena cava syndrome and [ch104 ¶2-¶8]

supportive care [ch81 ¶28-¶51]

death and dying [ch81 ¶47-¶49]

for effusions [ch81 ¶37-¶40]

end-of-life decisions [ch81 ¶50]

for nausea [ch81 ¶33-¶36]

nutritional [ch81 ¶41-¶43]

for pain [ch81 ¶29-¶32]

psychosocial [ch81 ¶44-¶45]

surgical therapy for [ch81 ¶16]

testicular [ch98]

treatment [ch86]

complications [ch81 ¶19-¶24]

of infections [ch87 ¶41-¶52]

long-term follow-up [ch81 ¶25-¶27]

plans [ch81 ¶16]

treatment-related emergencies [ch104 ¶54-¶76]

tumor burden [ch81 ¶12]

tumor-lysis syndrome and [ch104 ¶54-¶59]

tumor markers [ch81 ¶22] [ch81 Table3]

typhlitis and [ch104 ¶73]

of unknown primary site (CUPS) [ch101]

 

[see also: Metastases, of unknown primary site]

urinary obstruction and [ch104 ¶15-¶17]

viral infections and [ch182 ¶32]

 

C *CA 19-9 -- Cancer -- Cancrum oris (noma) -- Capnocytophaga ochracea Capnocytophaga sputigena -- Carcinoma(s) Carcinoma -- Cardiac output Cardiac performance, control of -- Cardinal manifestations and presentation of disease Cardiobacterium hominis -- Cardiovascular disease Cardiovascular system -- Cefuroxime -- Celiac catheterization, for pancreatic disease -- Central nervous system -- Central venous access, for parenteral nutrition -- Cervical spondylosis Cervicitis, mucopurulent (MPC) -- Chemoprevention, of cancer Chemoreceptor trigger zone -- Chemotherapy Chenodeoxycholate (CDCA) -- Chlamydial infections Chlamydia pneumoniae -- Chloroquine Chlorothiazide, for heart failure -- Cholera (Vibrio cholerae) Cholera vaccine -- Chromatin Chromium -- Cidofovir Cigar smoking -- Cirrhosis Cisapride -- Clonidine Cloning -- Coagulation disorders Coagulation factor(s) -- Cognitive dysfunction Cognitive evoked potentials -- Colon cancer Colonic diverticula -- Complement pathway Complement system -- Congenital heart disease Congenital muscular dystrophy -- Copolymer I (COP-I), for multiple sclerosis Copper -- Cortisol Cortisol-binding globulin (CGB; transcortin) -- Cranial nerves Cranial neuralgias -- Cryptococcosis (Cryptococcus neoformans) Cryptogenic fibrosing alveolitis -- Cyanosis Cyclic AMP response element binding (CREB) -- Cystic fibrosis Cystic teratomas, and chronic anovulation -- Cytomegalovirus (CMV) Cytosine arabinoside -- Cytotoxins

 

 

C-1 Esterase Deficiency

C-11 Hydroxylase Deficiency

Cachexia

Cadmium Poisoning

Calcinosis Cutis

Campylobacter Infections

Candidiasis (Mucosal)

Candidiasis

Cannabis Compound Abuse

Caprine Arthritis Encephalitis Virus

Carcinoid Tumor, Pancreatic

Carcinoid Tumor, Intestinal

Carcinoma of the Ampulla of Vater

Cardiac Neoplasms, Primary

Cardiac Sarcoma

Cardiac Rhabdomyoma

Cardiac Lipoma

Cardiac Amyloidosis

Cardiac Tamponade

Cardiac Hemangioma

Cardiac Fibroma

Cardiac Death, Sudden

Cardiac Cirrhosis

Cardiac Arrest

Cardiobacterium

Cardiogenic Shock

Cardiomyopathy, Diabetic

Cardiomyopathy, Hypertrophic

Cardiovascular Collapse

Carotid Sinus Hypersensitivity

Cat Scratch Disease

Caustic Ingestion

Cavernous Hemangioma

Celiac Sprue

Cellulitis

Cervical Cancer

Cervicitis

Cestode Diseases

Chagas Disease (American Trypanosomiasis)

Chancroid

Charcot-Leyden Crystal

Cheese Washer's Lung

Cheilitis Granulomatosa (Miescher-Melkersson-Rosenthal Syndrome)

Chemical Worker's Lung

Cherry Hemangioma

Chest Pain

Chickenpox

Chiggers

Chikungunya Viral Arthritis

CHILD Syndrome

Chlamydia Pneumonia

Chlamydial Genitourinary Infections

Chlorphenesin Poisoning

Choanal Atresia

Cholangiocarcinoma

Cholangiohepatitis

Cholangiosarcoma

Cholangitis

Cholecystitis

Cholecystopathy, Acalculous

Cholecystosis, Hypertrophic

Choledochal Cysts

Choledocholithiasis

Cholelithiasis

Cholera

Cholestasis

Cholesteatoma

Cholesterol Granuloma

Cholesterolosis

Chondrodermatitis Nodularis Helicis

Chondromas of Skin and Soft Tissue

Choriocarcinoma, Testicular

Christmas Disease (Hemophilia Type B)

Chromoblastomycosis

Chronic Mesenteric Ischemia

Chronic Gastric Ulcer

Chronic Active Hepatitis

Chronic Bronchitis

Chronic Obstructive Pulmonary Disease

Chronic Myelogenous Leukemia

Chronic Myelomonocytic Leukemia

Chronic Lymphocytic Leukemia

Chronic Renal Failure

Chronic Fatigue Syndrome

Chronic Venous Insufficiency

Churg-Strauss Syndrome (Allergic Granulomatosis)

Churilov's Disease (Hemorrhagic Fever)

Chyle Fistula

Chylothorax

Chylous Ascites

Cicatricial Pemphigoid

Cirrhosis, Postviral

Cirrhosis, Cryptogenic

Clostridial Cholecystitis

Clostridial Necrotizing Fasciitis

Clostridial Gas Gangrene

Clostridium Difficile Colitis

CMV Esophagitis

CMV Retinitis

CMV Colitis

CMV Hepatitis

CMV Pneumonia

Coal Worker's Pneumoconiosis

Cocaine Abuse and Poisoning

Coccidioidomycosis

Coffee Worker's Lung

Cold Agglutinin Immune Hemolysis

Cold Hemoglobinuria, Paroxysmal

Cold Agglutinin Disease

Colloid Milium

Colon Cancer, Adenocarcinoma

Colonic Polyps

Colonic Obstruction

Colorado Tick Fever

Complement Deficiencies

Complement Component 1 Inhibitor Deficiency

Complex IV Deficiency

Complex II Deficiency

Complications of Dermatologic Laser Surgery

Compost Lung

Cone Shell Poisoning

Confluent and Reticulated Papillomatosis

Congenitally Corrected Transposition

Conn's Syndrome

Connective Tissue Nevus

Constipation

Contact Dermatitis (Irritant)

Contact Dermatitis (Allergic)

Cooley's Anemia

Coproporphyria, Hereditary

Cor Pulmonale

Cor Triatriatum

Coral Wounds and Stings

Coronary Artery Vasospasm

Coronary Artery Atherosclerosis

Coronary Artery Anomalies

Coronaviruses

Corpus Luteum Rupture

Corrosive Gastritis

Corynebacterium Infections

Cowden's Disease (Multiple Hamartoma Syndrome)

Cowpox

Cowpox Infection (Human)

Coxsackieviruses

Crabs

Crest Syndrome

Cretinism

Crigler-Nijjar Syndrome

Crohn's Disease

Cryoglobulinemia

Cryoimmunoglobulinemia, Essential Mixed

Cryptochordism

Cryptococcosis

Cryptosporidiosis

Cushing's Syndrome

Cushing's Ulcer

Cutaneous Horn

Cutaneous Laser Resurfacing

Cutaneous Larva Migrans

Cutaneous Larva Migrans

Cutaneous CD30+ (Ki-1) Anaplastic Large-Cell Lymphoma

Cutaneous T Cell Lymphoma

Cutaneous Horn

Cutaneous Laser Resurfacing

Cutaneous T Cell Lymphoma

Cutaneous Larva Migrans

Cutaneous Laser Resurfacing

Cutaneous CD30+ (Ki-1) Anaplastic Large-Cell Lymphoma

Cutaneous T Cell Lymphoma

Cutis Laxa (Elastolysis)

Cyanide Poisoning

Cyanosis

Cyclobenzaprine Poisoning

Cyclooxygenase Deficiency

Cylindroma

Cystadenomas, Hepatic

Cystathioninuria

Cystic Fibrosis

Cysticercosis

Cystinosis

Cystinuria

Cystitis

Cystosarcoma Phyllodes

Cytochrome B5 Reductase Deficiency

Cytochrome P-450 Deficiency

Cytochrome C Oxidase Deficiency

Cytomegalovirus